Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/4195
Full metadata record
DC FieldValueLanguage
dc.contributor.authorde Mulder, P.H.M.-
dc.contributor.authorOosterhof, G.O.N.-
dc.contributor.authorBouffioux, Christophe-
dc.contributor.authorvan Oosterom, A.T.-
dc.contributor.authorVermeylen, K.-
dc.contributor.authorSYLVESTER, Richard-
dc.date.accessioned2007-12-20T15:47:06Z-
dc.date.available2007-12-20T15:47:06Z-
dc.date.issued1995-
dc.identifier.citationThe British journal of cancer, 71. p. 371-375-
dc.identifier.urihttp://hdl.handle.net/1942/4195-
dc.language.isoen-
dc.titleEORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma-
dc.typeJournal Contribution-
dc.identifier.epage375-
dc.identifier.spage371-
dc.identifier.volume71-
dc.bibliographicCitation.oldjcat-
item.fullcitationde Mulder, P.H.M.; Oosterhof, G.O.N.; Bouffioux, Christophe; van Oosterom, A.T.; Vermeylen, K. & SYLVESTER, Richard (1995) EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. In: The British journal of cancer, 71. p. 371-375.-
item.fulltextNo Fulltext-
item.contributorde Mulder, P.H.M.-
item.contributorOosterhof, G.O.N.-
item.contributorBouffioux, Christophe-
item.contributorvan Oosterom, A.T.-
item.contributorVermeylen, K.-
item.contributorSYLVESTER, Richard-
item.accessRightsClosed Access-
Appears in Collections:Research publications
Show simple item record

Page view(s)

76
checked on Nov 7, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.